Tectonic Therapeutic, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tectonic Therapeutic, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2024.
  • Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $403K, a 45.5% increase year-over-year.
  • Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.37M, a 30.5% decline year-over-year.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.89M, a 40.2% decline from 2022.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.5M, a 38% decline from 2021.
  • Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.6M, a 18.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.37M $403K +$126K +45.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $5.24M $878K -$1.65M -65.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $6.89M $1.87M -$389K -17.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $7.28M $2.22M -$437K -16.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.72M $277K -$2.96M -91.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $10.7M $2.53M -$848K -25.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $11.5M $2.25M -$1.83M -44.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $13.4M $2.66M -$2.51M -48.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $15.9M $3.23M -$1.46M -31.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $17.3M $3.38M -$1.26M -27.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $18.6M $4.08M -$18K -0.44% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $18.6M $5.17M +$364K +7.58% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $18.2M $4.69M +$792K +20.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $17.4M $4.64M +$1.81M +64.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $15.6M $4.1M +$2.22M +118% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $13.4M $4.81M +$3.01M +167% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $10.4M $3.9M +$2.24M +134% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.17M $2.82M +$1.37M +94% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $6.8M $1.89M +$805K +74.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $6M $1.8M +$1.25M +227% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $4.75M $1.66M +$1.21M +264% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $3.54M $1.46M +$1.35M +1235% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.2M $1.08M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $550K +$504K +1096% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $457K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $109K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 $46K Jun 24, 2017 Sep 30, 2017 10-Q 2018-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.